Creative Medical Technology Holdings Future Growth
Future criteria checks 5/6
Creative Medical Technology Holdings is forecast to grow earnings and revenue by 67.1% and 67.7% per annum respectively while EPS is expected to grow by 65.3% per annum.
Key information
67.1%
Earnings growth rate
65.3%
EPS growth rate
| Biotechs earnings growth | 27.1% |
| Revenue growth rate | 67.7% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 24 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 23 | 9 | N/A | N/A | 1 |
| 12/31/2025 | 1 | -4 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -5 | N/A | N/A | 1 |
| 6/30/2024 | 0 | -6 | -6 | -6 | N/A |
| 3/31/2024 | 0 | -5 | -5 | -5 | N/A |
| 12/31/2023 | 0 | -5 | -8 | -8 | N/A |
| 9/30/2023 | 0 | -10 | -10 | -10 | N/A |
| 6/30/2023 | 0 | -9 | -9 | -9 | N/A |
| 3/31/2023 | 0 | -10 | -10 | -10 | N/A |
| 12/31/2022 | 0 | -10 | -8 | -8 | N/A |
| 9/30/2022 | 0 | -8 | -5 | -5 | N/A |
| 6/30/2022 | 0 | -9 | -5 | -5 | N/A |
| 3/31/2022 | 0 | -10 | -3 | -3 | N/A |
| 12/31/2021 | 0 | 19 | -2 | -2 | N/A |
| 9/30/2021 | 0 | -16 | -1 | -1 | N/A |
| 6/30/2021 | 0 | -13 | -1 | -1 | N/A |
| 3/31/2021 | 0 | -12 | -1 | -1 | N/A |
| 12/31/2020 | 0 | -36 | -1 | 0 | N/A |
| 9/30/2020 | 0 | -3 | -1 | -1 | N/A |
| 6/30/2020 | 0 | -6 | -1 | -1 | N/A |
| 3/31/2020 | 0 | -4 | -1 | -1 | N/A |
| 12/31/2019 | 0 | -8 | -1 | -1 | N/A |
| 9/30/2019 | 0 | -1 | -1 | -1 | N/A |
| 6/30/2019 | 0 | -1 | -1 | -1 | N/A |
| 3/31/2019 | 0 | -7 | -1 | -1 | N/A |
| 12/31/2018 | 0 | -14 | -1 | -1 | N/A |
| 9/30/2018 | 0 | -17 | -1 | -1 | N/A |
| 6/30/2018 | 0 | -16 | -1 | -1 | N/A |
| 3/31/2018 | 0 | -10 | N/A | -1 | N/A |
| 12/31/2017 | 0 | -3 | N/A | -1 | N/A |
| 9/30/2017 | N/A | -1 | N/A | -1 | N/A |
| 6/30/2017 | N/A | -2 | N/A | -1 | N/A |
| 3/31/2017 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CELZ is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: CELZ is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: CELZ is expected to become profitable in the next 3 years.
Revenue vs Market: CELZ's revenue (67.7% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CELZ's revenue (67.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CELZ's Return on Equity is forecast to be high in 3 years time